Estazolam is also sometimes used as a preoperative sleep aid.

Estazolam is prescribed for the short-term treatment of certain sleep disorders.

Estazolam is a drug with the potential for misuse.

A primate study found that estazolam has abuse potential.

Estazolam was found to be more potent however.

Drugs in the same class (benzodiazepine) as estazolam can only be prescribed by a physician.

Estazolam belongs in the class of drugs known as benzodiazepines, which should only be prescribed by a health care professional.

Estazolam should only be used short term and at the lowest effective dose to avoid complications related to long-term use.

Estazolam should be used with caution by pregnant women, the elderly, and those with a history of substance abuse.

The major metabolite of estazolam is 4-hydroxyestazolam.

The other two metabolites are alpha-hydroxyalprazolam and estazolam.

The most common side-effects associated with the use of products containing estazolam are dizziness and drowsiness.

Other side effects of estazolam include somnolence, dizziness, hypokinesia, and abnormal coordination.

Alcohol enhances the sedative hypnotic properties of estazolam.

Estazolam is classed as a "triazolo" benzodiazepine drug.

Estazolam is an intermediate acting benzodiazepine.

Sleepees was the subject of a national recall in Canada following the news that it was adulterated with the prescription drug estazolam.

Estazolam exerts its therapeutic effects via its benzodiazepines receptor agonist properties.

The photic driving response elicited by a flash light in the visual cortex is significantly suppressed by estazolam.

Combination with non-pharmacological options for sleep management results in long-term improvements in sleep quality after discontinuation of short-term estazolam therapy.

Among the benzodiazepines approved in the US for the treatment of insomnia, the fast acting ones with short such as estazolam, triazolam, and temazepam are recommended.

Compared with the benzodiazepines including estazolam, the nonbenzodiazepine sedative-hypnotics appeared to offer few, if any, significant clinical advantages in efficacy or tolerability in elderly persons.

Manufacturers warn in package inserts about an interaction with Ritonavir, but clinical interactions of Ritonavir with estazolam have not yet been described.

Estazolam at high doses decreases histamine turnover via its action at the benzodiazepine-GABA receptor complex in mouse brains.

The side-effects associated with the use of products containing estazolam vary according to the individual and can include dizziness, drowsiness, confusion, depression, loss of memory and hallucinations.